Add Company
Join Now

NeuCyte Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NeuCyte's estimated annual revenue is currently $2.5M per year.(i)
  • NeuCyte's estimated revenue per employee is $155,000

Employee Data

  • NeuCyte has 16 Employees.(i)
  • NeuCyte grew their employee count by 33% last year.

NeuCyte's People

NameTitleEmail/Phone
1
Head Business DevelopmentReveal Email/Phone
2
Director Drug DiscoveryReveal Email/Phone
3
Director, Head Neuroscience and Rare DiseasesReveal Email/Phone
4
Research Operations ManagerReveal Email/Phone
5
Scientist IReveal Email/Phone
6
President/Co-FounderReveal Email/Phone
7
Corporate Development LeadReveal Email/Phone
8
Scientist - Stem CellReveal Email/Phone
9
Senior Research Associate Reveal Email/Phone
10
Scientist II, Neuroscience and Stem Cell BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is NeuCyte?

The high attrition rates of novel drugs in clinical trials is a clear indication that current preclinical testing is failing to predict compounds that will reach the market. NeuCyte, is an early-stage biotechnology company focused on advancing the drug discovery process by using cell based target-identification and drug-discovery platforms. Our technology accelerates the lead drug identification and optimization process. NeuCyte's unique human neural platform allows for the evaluation of human specific neural phenotypes that are not identifiable in traditional animal models. This allows for a more reliable predictor of drug efficacy and potential neurotoxicity. NeuCyte's all-star staff and scientific advisory board is comprised of some of the top stem cell biologists and neuroscientists in the world. The vast knowledge of our team gives us an unrivaled competitive advantage, which allows us to address the unmet needs of patients with neurological disorders.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M1633%N/A
#2
$2.5M160%$47M
#3
$3.3M17-6%N/A
#4
$3.4M17183%$8M
#5
$1.5M170%N/A